ArticleDermatologic therapy2021
Generalized pustular psoriasis following COVID-19.
Article in Dermatologic therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 29 citations in OpenAlex.
- COVID-19 and exacerbation of dermatological diseases: A review of the available literature.Dermatologic therapy · 2021Pooled it
- National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments.Journal of the American Academy of Dermatology · 2021Guideline
- Pustular psoriasis flare following COVID-19 infection: a case report and literature review.Frontiers in immunology · 2026Review
- COVID-19 and Autoimmunity in Dermatology: A Moroccan Case Series and Literature Review.Cureus · 2024Article
- Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest Registries.Psoriasis (Auckland, N.Z.) · 2024Article
- Autoimmune and Autoinflammatory Connective Tissue Disorders Following COVID-19.JAMA network open · 2023Article
- Generalized Pustular Psoriasis: A Review on Clinical Characteristics, Diagnosis, and Treatment.Dermatology and therapy · 2023Review
- Article
- A case of new-onset acute generalized pustular psoriasis following Pfizer-BioNTech COVID-19 vaccine.Dermatologic therapy · 2022Article
- Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities.Journal of clinical medicine · 2022Review
- Diagnosis of Generalized Pustular Psoriasis.American journal of clinical dermatology · 2022Review
- De novo generalized pustular psoriasis following Oxford-AstraZeneca COVID-19 vaccine.Clinical and experimental dermatology · 2022Article
- Multisystem Inflammatory Syndrome and Autoimmune Diseases Following COVID-19: Molecular Mechanisms and Therapeutic Opportunities.Frontiers in molecular biosciences · 2022Review
- Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic.Journal of clinical medicine · 2021Review
- Vaccines Against SARS-CoV-2 in Psoriasis Patients on Immunosuppressive Therapy: Implications of Vaccination Nationwide Campaign on Clinical Practice in Italy.Dermatology and therapy · 2021Review
- New-onset guttate psoriasis secondary to COVID-19.Clinical case reports · 2021Article
- Biologics for Psoriasis during the COVID-19 Pandemic.Journal of clinical medicine · 2021Review
- Pansclerotic Morphea Following COVID-19: A Case Report and Review of Literature on Rheumatologic and Non-rheumatologic Dermatologic Immune-Mediated Disorders Induced by SARS-CoV-2.Frontiers in medicine · 2021Article
- Acrodermatitis Continua of Hallopeau Evolving into Generalized Pustular Psoriasis Following COVID-19: A Case Report of a Successful Treatment with Infliximab in Combination with Acitretin.Biologics : targets & therapy · 2021Article
- Biologics for Psoriasis During the COVID-19 Pandemic.Frontiers in medicine · 2021Review
Corrections and comments
- Commented on by
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.